NuVasive expanded its complex spine portfolio with the global commercial launch of Reline 3D™, a posterior fixation system to treat pediatric patients with spinal deformities. Reline 3D is presently available in the U.S. and European markets, and is expected to launch in other countries in 2021.
Reline 3D is optimized to treat adolescent idiopathic scoliosis. It unifies current deformity techniques involving multi-step, single-plane correction into one procedure, and provides simultaneous three-dimensional deformity correction through a simplified procedure.
Reline 3D is an extension of the Reline® spinal fixation portfolio that includes Reline Open, Reline MAS, Reline Trauma and Reline Small Stature.
"Reline 3D represents a true procedural solution that increases efficiencies and supports a less invasive approach to addressing complex pathologies," said Matt Link, president of NuVasive. "As an innovative leader in less invasive surgery, NuVasive is committed to providing industry-leading procedures and technologies that enable health systems and surgeons to provide the same standard of care while reducing operative time and length of stay in the hospital. With this launch of Reline 3D, we have expanded this commitment to the AIS patient population."